Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 6:49 AM
Study NCT ID:
NCT01162460
Status:
COMPLETED
Last Update Posted:
2016-09-29
First Post:
2010-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
Sponsor:
Bial - Portela C S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
None
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-13
First Submit QC Date:
None
Study First Post Date:
2010-07-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-28
Last Update Post Date:
2016-09-29
Last Update Post Date Type:
ESTIMATED